Clinical Trial Update: A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on Dialysis [Phase 2]

View source ↗

Summary

Phase 2 tolerability study of Oxylanthanum carbonate in patients with chronic kidney disease on dialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Oxylanthanum carbonate (oxylanthanum carbonate)

Snippet

Sponsor: Unicycive Therapeutics, Inc | Conditions: Chronic Kidney Disease Requiring Chronic Dialysis | Phase 2 | Status: COMPLETED